Methylprednisolone Acetate

   
Google
 
Web NewDrugInformation.com

Methylprednisolone Acetate


Drug - Methylprednisolone Acetate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Methylprednisolone Acetate
Multiple ingredients are in alphabetical order.

Strength - 80MG/ML
The potency of the active ingredient(s), Methylprednisolone Acetate. May repeat for multiple part products.

Applicant - AKORN
The firm name holding legal responsibility for Methylprednisolone Acetate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 086903
The FDA assigned number to Methylprednisolone Acetate. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Methylprednisolone Acetate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 20, 1982
The date Methylprednisolone Acetate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Methylprednisolone Acetate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Methylprednisolone Acetate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Akorn Inc
The full name of the firm holding legal responsibility for the new application of Methylprednisolone Acetate.

Methylprednisolone Acetate